154 related articles for article (PubMed ID: 28379474)
21. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
[TBL] [Abstract][Full Text] [Related]
22. Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism.
Guo Z; Poglitsch M; Cowley D; Domenig O; McWhinney BC; Ungerer JPJ; Wolley M; Stowasser M
Hypertension; 2020 Aug; 76(2):488-496. PubMed ID: 32507039
[TBL] [Abstract][Full Text] [Related]
23. Aldosterone-to-renin ratio (ARR) as a screening tool for primary aldosteronism (PA).
Lin CH; Lin CH; Chung MC; Hung CS; Tseng FY; Er LK; Jia-Yin Hou C; Lin YH; Wu VC; Cheng HM; Kao HL; Wu KD; Lai TS
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S98-S103. PubMed ID: 37173226
[TBL] [Abstract][Full Text] [Related]
24. Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
Lőcsei Z; Horváth D; Rácz K; Szabolcs I; Kovács GL; Toldy E
Clin Biochem; 2012 Nov; 45(16-17):1516-8. PubMed ID: 22750772
[TBL] [Abstract][Full Text] [Related]
25. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
26. Aldosterone, Renin, and Aldosterone-to-Renin Ratio Variability in Screening for Primary Aldosteronism.
Ng E; Gwini SM; Libianto R; Choy KW; Lu ZX; Shen J; Doery JCG; Fuller PJ; Yang J
J Clin Endocrinol Metab; 2022 Dec; 108(1):33-41. PubMed ID: 36179243
[TBL] [Abstract][Full Text] [Related]
27. Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.
Jansen PM; van den Born BJ; Frenkel WJ; de Bruijne EL; Deinum J; Kerstens MN; Smulders YM; Woittiez AJ; Wijbenga JA; Zietse R; Danser AH; van den Meiracker AH
J Hypertens; 2014 Jan; 32(1):115-26. PubMed ID: 24018605
[TBL] [Abstract][Full Text] [Related]
28. Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney disease: the Ohasama Study.
Terata S; Kikuya M; Satoh M; Ohkubo T; Hashimoto T; Hara A; Hirose T; Obara T; Metoki H; Inoue R; Asayama K; Kanno A; Totsune K; Hoshi H; Satoh H; Sato H; Imai Y
J Hypertens; 2012 Aug; 30(8):1632-8. PubMed ID: 22595958
[TBL] [Abstract][Full Text] [Related]
29. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
[TBL] [Abstract][Full Text] [Related]
30. Rapid screening test for primary hyperaldosteronism: ratio of plasma aldosterone to renin concentration determined by fully automated chemiluminescence immunoassays.
Perschel FH; Schemer R; Seiler L; Reincke M; Deinum J; Maser-Gluth C; Mechelhoff D; Tauber R; Diederich S
Clin Chem; 2004 Sep; 50(9):1650-5. PubMed ID: 15247156
[TBL] [Abstract][Full Text] [Related]
31. A screening procedure for primary aldosteronism based on the Diasorin Liaison automated chemiluminescent immunoassay for direct renin.
Dorrian CA; Toole BJ; Alvarez-Madrazo S; Kelly A; Connell JM; Wallace AM
Ann Clin Biochem; 2010 May; 47(Pt 3):195-9. PubMed ID: 20392751
[TBL] [Abstract][Full Text] [Related]
32. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
33. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
Endocrine; 2012 Aug; 42(1):182-9. PubMed ID: 22302679
[TBL] [Abstract][Full Text] [Related]
35. Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.
Pilz S; Trummer C; Verheyen N; Schwetz V; Pandis M; Aberer F; Grübler MR; Meinitzer A; Bachmann A; Voelkl J; Alesutan I; Catena C; Sechi LA; März W; Obermayer-Pietsch B; Tomaschitz A
Horm Metab Res; 2018 May; 50(5):375-382. PubMed ID: 29723896
[TBL] [Abstract][Full Text] [Related]
36. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
37. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
[TBL] [Abstract][Full Text] [Related]
38. Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.
Leal Reyna M; Gómez RM; Lupi SN; Belli SH; Fenili CA; Martínez MS; Ruibal GF; Rossi MA; Chervin RA; Cornaló D; Contreras LN; Costa L; Nofal MT; Damilano SA; Pardes EM
Arch Endocrinol Metab; 2015 Oct; 59(5):441-7. PubMed ID: 26222233
[TBL] [Abstract][Full Text] [Related]
39. The ovarian cycle as a factor of variability in the laboratory screening for primary aldosteronism in women.
Fommei E; Ghione S; Ripoli A; Maffei S; Di Cecco P; Iervasi A; Turchi S
J Hum Hypertens; 2009 Feb; 23(2):130-5. PubMed ID: 18769443
[TBL] [Abstract][Full Text] [Related]
40. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.
Schunkert H; Danser AH; Hense HW; Derkx FH; Kürzinger S; Riegger GA
Circulation; 1997 Jan; 95(1):39-45. PubMed ID: 8994414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
